StockNews.AI
GRAL
StockNews.AI
4 hrs

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

1. GRAIL will present at Morgan Stanley's healthcare conference on Sep. 9. 2. The presentation aims to highlight GRAIL's cancer detection innovations. 3. GRAIL focuses on early cancer detection using advanced technologies. 4. The webcast will be available for replay for 30 days. 5. Investors are encouraged to tune into GRAIL's investor relations page.

6m saved
Insight
Article

FAQ

Why Bullish?

Upcoming presentation showcases GRAIL's positioning in innovative cancer detection, hinting future growth.

How important is it?

The presentation at a prominent conference may increase visibility and investor interest in GRAIL.

Why Short Term?

Market sentiment may react positively leading up to the conference, influencing short-term price movement.

Related Companies

MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sep. 9 at 1:50 p.m. ET

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-morgan-stanley-23rd-annual-global-healthcare-conference-302538075.html

SOURCE GRAIL, Inc.

Related News